arrow
Y

Yara Abdou

university of north carolina lineberger comprehensive cancer center
H指数:17
被引数:1,419

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CLTR-10 PHASE I/II STUDY OF STEREOTACTIC RADIOSURGERY WITH CONCURRENT OLAPARIB FOLLOWED BY ADJUVANT DURVALUMAB AND PHYSICIAN’S CHOICE SYSTEMIC THERAPY IN SUBJECTS WITH BREAST CANCER BRAIN METASTASES (SOLARA)

CLTR-10 I/II期研究:对于乳腺癌脑转移患者,进行立体定向放射手术联合奥拉帕利,随后进行辅助度伐利尤单抗和医生选择系统性治疗的临床研究(SOLARA)

2026-08-070
OA
Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)

在影响开始的地方进行投资:乳腺癌研究基金会早期职业研究员工作组建议(第一部分,共两部分)

2026-05-010
PRE
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline

术后放疗:ASTRO/ASCO/SSO临床实践指南

2025-09-160
PRE
Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline

乳腺癌根治术后放疗:ASTRO/ASCO/SSO临床实践指南

2025-09-160
PRE
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer☆

循环肿瘤DNA突变景观和进展后使用CDK4/6抑制剂的动态变化:PACE II期临床试验中转移性HR阳性/HER2阴性乳腺癌☆

2025-07-250
OAAI
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium

乳腺癌管理中的争议与关键知识空白专家观点:第一届弥合乳腺癌知识空白研讨会的会议录

2025-04-080
PRE
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
CANCER
IF5.1
2024-05-166
OAAI